The 10 Companies Booming in Healthcare Sector

The cost of research for new drugs has almost
tripled over the last 25 years and new models are
emerging to face these increasing expenses.
Multinational pharmaceutical companies are deriving an
even larger share of their revenues from biotech
acquisitions or external discovery, and an increasing
focus is put on clinical development operational
improvements and optimization.
Novotech is internationally recognized as the leading
regional full-service contract research organization
(CRO) in Asia-Pacific and is dedicated to supporting
biotech companies in their drug development by tapping
into the benefits of the region. With a focus on clinical
monitoring, it has been instrumental in the success of
hundreds of Phase I - IV clinical trials in the Asia Pacific
region.
Headquartered in Sydney, Novotech has been delivering
CRO services in the region for more than 23 years. It has
offices in twelve countries, including two customerfacing
offices in the US, and more than 550 staff to
accommodate increased demand from international
biotech companies for specialist clinical services.
Strong Focus on Asia-Pacific with a Global Reach
Novotech delivers clinical development services across
all clinical trial phases and therapeutic areas. These
include feasibility assessments, ethics committee and
regulatory submissions, data management, statistical
analysis, medical monitoring, safety services, central lab
services, report write-up to ICH requirements, and
project and vendor management. The company’s strong
Asia Pacific presence allows them to run clinical trials in
all key regional markets. It also has worldwide reach
through the company’s network of strategic partners.
Full Service for Biotechnology Companies
Novotech is known as the leading regional CRO in the
Asia-Pacific region and the biotech sector. The company
and its employees have won numerous awards and
recognitions in the CRO industry over the last several
years and has been dedicated to delivering consistently
high-quality service for its clients. In addition, the
company ensures that the customer satisfaction is closely
and objectively monitored across a range of KPIs
throughout the lifespan of each project.
Speaking of what sets them apart in today’s highly
competitive global world, Dr. John Moller, the CEO of
Novotech, said, “Novotech is focused on delivering
world-class clinical services in the Asia-Pacific region
for the biotech sector. We offer the very latest in Oracle
and Medidata technology, and all our projects are
measured on quality of service and customer satisfaction
throughout every stage of our engagement.”
The customers of the company value its leadership as a
regional CRO specialist, who can understand local
cultures, customs, regulations, and have developed deep
relationships with the key investigators in the region.
Novotech follows a unique strategy for all its clients’
projects. When discussing a new potential project with a
client, the company brings in its senior clinical staff,
country managers, and potentially investigators into the
discussions as early as possible. Through this, it ensures
that the sponsor can gain the confidence that their project
will receive the attention they may not otherwise have
with global CRO players.
In addition to this, Novotech has a significant focus on
appointing and retaining the best people and is strongly
passionate about developing its employees. In fact, in the
year of 2018, 30% of the company’s employees were
promoted.
Focused on Client Satisfaction
Novotech has implemented a systematic mechanism of
monitoring customer and investigator satisfaction across
a range of items. It has invested in new technology and
established clear processes to systematically reach out to
its customers after key milestones for each project. The
company finds this initiative very important as it nurtures
relationships with its clients to address potential issues
well in advance and ensures continuous improvement in
the services it provides. Validating the success of this
approach is Novotech’s excellent levels of client
satisfaction - mostly 8 and 9 out of 10 - and especially
project communications which consistently scores above
9 out of 10.
Following are some feedback comments from from
Novotech clients.
“We’re delighted with the way our project was managed.
The structure of having the study team together with the
governance team was effective. The team was very